A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells.


Journal

Experimental cell research
ISSN: 1090-2422
Titre abrégé: Exp Cell Res
Pays: United States
ID NLM: 0373226

Informations de publication

Date de publication:
15 05 2019
Historique:
received: 25 09 2018
revised: 11 02 2019
accepted: 13 02 2019
pubmed: 18 2 2019
medline: 27 5 2020
entrez: 18 2 2019
Statut: ppublish

Résumé

Metastatic progression is a major cause of mortality in cervical cancers, but factors regulating migratory and pre-metastatic cell populations remain poorly understood. Here, we sought to assess whether a SUV39H1-low chromatin state promotes migratory cell populations in cervical cancers, using meta-analysis of data from The Cancer Genome Atlas (TCGA), immunohistochemistry, genomics and functional assays. Cervical cancer cells sorted based on migratory ability in vitro have low levels of SUV39H1 protein, and SUV39H1 knockdown in vitro enhanced cervical cancer cell migration. Further, TCGA SUV39H1-low tumours correlated with poor clinical outcomes and showed gene expression signatures of cell migration. SUV39H1 expression was examined within biopsies, and SUV39H1

Identifiants

pubmed: 30772380
pii: S0014-4827(18)30986-8
doi: 10.1016/j.yexcr.2019.02.010
pii:
doi:

Substances chimiques

Chromatin 0
Histones 0
Repressor Proteins 0
SUV39H1 protein, human EC 2.1.1.
Methyltransferases EC 2.1.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

206-216

Subventions

Organisme : Medical Research Council
ID : G0701175
Pays : United Kingdom
Organisme : DBT-Wellcome Trust India Alliance
ID : IA/E/14/1/501773
Pays : India

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Calvin Rodrigues (C)

National Centre for Biological Sciences, Tata Institute of Fundamental Research, GKVK-UAS, Bangalore 560065, Karnataka, India.

Chitra Pattabiraman (C)

National Centre for Biological Sciences, Tata Institute of Fundamental Research, GKVK-UAS, Bangalore 560065, Karnataka, India.

Anjali Vijaykumar (A)

National Centre for Biological Sciences, Tata Institute of Fundamental Research, GKVK-UAS, Bangalore 560065, Karnataka, India.

Reety Arora (R)

National Centre for Biological Sciences, Tata Institute of Fundamental Research, GKVK-UAS, Bangalore 560065, Karnataka, India.

Suma Mysore Narayana (SM)

Department of Pathology, Kidwai Cancer Institute, Bangalore, India.

Rekha V Kumar (RV)

Department of Pathology, Kidwai Cancer Institute, Bangalore, India.

Dimple Notani (D)

National Centre for Biological Sciences, Tata Institute of Fundamental Research, GKVK-UAS, Bangalore 560065, Karnataka, India.

Patrick Varga-Weisz (P)

The Babraham Institute, Cambridge, UK; School of Biological Sciences, University of Essex, Colchester, UK.

Sudhir Krishna (S)

National Centre for Biological Sciences, Tata Institute of Fundamental Research, GKVK-UAS, Bangalore 560065, Karnataka, India. Electronic address: skrishna@ncbs.res.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH